| Application no. and date | 14724662.3 (espacenet) (Federated) (European Patent Register), 20140430 | | Patent/reg. no. and date | DK/EP 2992016, 20171018 | | Publication date | 20160309 | | Priority no. and date | US 201361818821 P, 20130502 | | EP pub. no. and date |
EP 2992016 20160309 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | 63314DK01 | | Inventor | KLEIN, Christian, Chruezacherweg 41
CH-8906 Bonstetten, CH,
UMANA, Pablo, Felsenrainstrasse 28
CH-8832 Wollerau, CH,
LANG, Sabine, Rebbergstrasse 36
CH-8102 Oberengstringen, CH,
POLSON, Andrew G., c/o Genentech Inc.
1 DNA Way
South San Francisco
California 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) | | Title | Kombinationsterapi af et afucosyleret CD20-antistof med et CD79b-antistof-lægemiddelkonjugat | | Int. application no. | EP2014058827 | | Int. publication no. | WO2014177615 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
